# RFPL2

## Overview
RFPL2 is a gene that encodes the protein ret finger protein-like 2, which is a member of the tripartite motif (TRIM) family. This family is characterized by a RING finger domain, a coiled-coil region, and a B30-2 domain, which are involved in mediating protein-protein interactions. The RFPL2 protein is primarily active in the nucleus and is thought to play a role in transcriptional regulation, potentially influencing neural development and cell proliferation. The gene is expressed in various tissues, including the prostate, and is associated with both sense and antisense transcripts, suggesting a role in post-transcriptional regulation. While the specific functions of RFPL2 in healthy human cells are not fully elucidated, its structural similarities to other RFPL family members imply significant regulatory roles (Seroussi1999Duplications).

## Structure
The RFPL2 gene encodes a protein that is part of the RFPL gene family, characterized by a tripartite structure typical of the RING-B30 family. This structure includes a RING-finger domain, a coiled-coil domain, and a B30-2 domain, which are known to mediate protein-protein interactions through homo- or heterodimerization (Seroussi1999Duplications). The RING-finger domain in RFPL2 is notable for having a serine residue replacing the typical cysteine found in similar proteins, which is a distinctive feature of the RFPL family (Seroussi1999Duplications).

The RFPL2 protein shares high nucleotide sequence identity with other members of the RFPL family, such as RFPL1 and RFPL3, with 95%-96% identity in their sense exons (Seroussi1999Duplications). Although specific details about the primary, secondary, tertiary, and quaternary structures of the RFPL2 protein are not provided, the presence of these domains suggests a role in facilitating complex protein interactions. The RFPL2 gene is also associated with sense and antisense transcripts, indicating potential involvement in post-transcriptional regulation (Seroussi1999Duplications).

## Function
The RFPL2 gene encodes a protein that is part of the tripartite motif (TRIM) family, characterized by a RING finger domain, coiled-coil region, and B30-2 domain. These structural features suggest that RFPL2 is involved in protein-protein interactions, potentially through homo- or heterodimerization (Seroussi1999Duplications). The RFPL2 protein is implicated in regulatory processes, possibly through its antisense transcripts, which may play a role in post-transcriptional regulation (Seroussi1999Duplications).

RFPL2 is expressed in various tissues, including the prostate, where it is represented by a single EST in the dBEST database, indicating its expression in this tissue (Seroussi1999Duplications). The protein is typically active in the nucleus, where it may interact with other proteins to modulate transcriptional activity. Although the specific function of RFPL2 in healthy human cells is not fully detailed, its structural similarities to other RFPL genes suggest a role in neural development and the regulation of cell proliferation and differentiation (Seroussi1999Duplications).

## Clinical Significance
The RFPL2 gene has been implicated in several diseases and conditions through alterations in its expression or interactions. In the context of Type 2 Diabetes Mellitus (T2DM) and Hepatocellular Carcinoma (HCC), RFPL2 is mentioned as potentially involved or having altered expression, although specific details on its role or impact in these diseases are not provided (Liu2019Key). In melanoma, RFPL2 has been identified as a novel regulator of the anti-tumor immune response, particularly in the context of immune checkpoint blockade (ICB) resistance. Enhancer reprogramming studies have suggested that RFPL2 may play a role in pathways associated with immune evasion and resistance to ICB therapy (Maitituoheti2022Enhancer).

In facioscapulohumeral muscular dystrophy (FSHD), RFPL2 is noted as a target gene of the transcription factor DUX4, which is overexpressed in this condition. The study of DUX4 dynamics in FSHD highlights the transcriptional regulation and expression variability of its target genes, including RFPL2, although specific diseases or conditions associated with RFPL2 mutations or expression alterations are not detailed (Cowley2023An). Overall, while RFPL2 is associated with various conditions, the precise mechanisms and clinical implications require further investigation.


## References


[1. (Seroussi1999Duplications) Eyal Seroussi, Darek Kedra, Hua-Qin Pan, Myriam Peyrard, Charles Schwartz, Peter Scambler, Dian Donnai, Bruce A. Roe, and Jan P. Dumanski. Duplications on human chromosome 22 reveal a novel ret finger protein-like gene family with sense and endogenous antisense transcripts. Genome Research, 9(9):803â€“814, September 1999. URL: http://dx.doi.org/10.1101/GR.9.9.803, doi:10.1101/gr.9.9.803. This article has 35 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/GR.9.9.803)

[2. (Cowley2023An) Matthew V Cowley, Johanna Pruller, Massimo Ganassi, Peter S Zammit, and Christopher RS Banerji. An in silico fshd muscle fiber for modeling dux4 dynamics and predicting the impact of therapy. eLife, May 2023. URL: http://dx.doi.org/10.7554/elife.88345, doi:10.7554/elife.88345. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.88345)

[3. (Liu2019Key) Gao-Min Liu, Hua-Dong Zeng, Cai-Yun Zhang, and Ji-Wei Xu. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathology - Research and Practice, 215(11):152510, November 2019. URL: http://dx.doi.org/10.1016/j.prp.2019.152510, doi:10.1016/j.prp.2019.152510. This article has 38 citations.](https://doi.org/10.1016/j.prp.2019.152510)

4. (Maitituoheti2022Enhancer) Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance. This article has 2 citations.